Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Prevalence of human leukocyte antigen (HLA)-B*57:01 in HIV-infected patients].

Mikrobiyoloji bulteni - 1 Oct 2016

Deveci Aydın, Çoban Ahmet Yılmaz, Durupınar Belma

Abstract excerpt

Deaths related with human immunodeficiency virus (HIV) infections have been decreased by the introduction of combined anti-retroviral therapy (ART) into the clinical practice. Combined ART usually consists of two nucleoside/nucleotide analogs reverse transcriptase inhibitors (NRTI) that is called backbone and a third drug that belongs to either non-nucleoside/nucleotide reverse transcriptase inhibitors (NNRTI),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Anti-Retroviral Agents
Share to Dideoxynucleosides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HLA-B Antigens

Share to Prevalence

Share to Reverse Transcriptase Inhibitors

Share to Turkey

Source

Identifiers

PMID: 28124959
DOI: 10.5578/mb.29179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Prevalence of human leukocyte antigen (HLA)-B*57:01 in HIV-infected patients].PMID 28124959Read ↗

High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.Semantic proximity Read ↗

Prevalence of HLA-B*57:01 and complete linkage disequilibrium with HCP5 rs2395029: Prevalence and DetectionSemantic proximity Read ↗

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjectsSemantic proximity Read ↗

Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers in People Living with HIV/AIDS in Türkiye.Semantic proximity Read ↗

Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot studySemantic proximity Read ↗

Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.Semantic proximity Read ↗

Prevalence of Human Leukocyte Antigen HLA-B*57:01 in Individuals with HIV in West and Central AfricaSemantic proximity Read ↗

HLA-B*5701 Allele Prevalence in Treatment-Naïve HIV-Infected Patients from ColombiaSemantic proximity Read ↗

Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV.Semantic proximity Read ↗

Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.Semantic proximity Read ↗

Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study.Semantic proximity Read ↗

HLA-B*57:01 typing in a Malaysian cohort: implications of abacavir hypersensitivity in people living with HIV.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.